Production of erythroid cells from human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPS)

Transfusion clinique et biologique : journal de la Société française de transfusion sanguine
D J Anstee

Abstract

Erythroid progenitors can be generated ex vivo from human embryonic stem cells (hESC) or human induced pluripotent stem cells (hiPS). Development of laboratory scale culture conditions capable of generating mature functional erythrocytes from human embryonic stem cells or human induced pluripotent stem cells would open the possibility for manufacture of therapeutic quantities of red cells and thereby new clinical transfusion products. Current attempts to produce erythrocytes from human embryonic stem cells reveal the need for greater understanding of the process whereby primitive erythropoiesis switches to definitive fetal and adult erythropoiesis and the factors driving erythrocyte maturation. Studies with human embryonic stem cells have already yielded encouraging results but functional mature biconcave erythrocytes have yet to be generated from these cells.

References

Nov 6, 2004·Blood·Mark J KouryMaurice C Bondurant
Dec 28, 2004·Nature Biotechnology·Marie-Catherine GiarratanaLuc Douay
Feb 24, 2006·Nature Reviews. Immunology·Anne Wilson, Andreas Trumpp
Dec 13, 2006·Experimental Hematology·Emmanuel N OlivierEric E Bouhassira
Mar 29, 2008·International Journal of Hematology·Akihito FujimiYoshiro Niitsu
Apr 9, 2008·Current Opinion in Hematology·James Palis
Jul 25, 2008·Blood·Joel Anne Chasis, Narla Mohandas
Aug 1, 2008·Proceedings of the National Academy of Sciences of the United States of America·Guillaume LettreStuart H Orkin
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Feng MaKohichiro Tsuji
Jun 16, 2009·Blood·Anders MälarstigUNKNOWN Genetic Analysis of Idiopathic Thrombophilia (GAIT) and Precocious Coronary Artery Disease (PROCARDIS) consortia
Aug 13, 2009·Nature·Michael J BolandKristin K Baldwin
Oct 3, 2009·Annals of the New York Academy of Sciences·Claudia LengerkeGeorge Q Daley
Dec 30, 2009·Blood·Jing LiuXiuli An
Feb 16, 2010·British Journal of Haematology·Jo MountfordMarc Turner
Mar 20, 2010·Science·Maya KasowskiMichael Snyder

❮ Previous
Next ❯

Citations

Dec 12, 2013·Applied Biochemistry and Biotechnology·Fatemeh KouhkanMasoud Soleimani
Jan 18, 2012·Expert Opinion on Drug Metabolism & Toxicology·Francesca PistollatoGlyn Stacey
Oct 9, 2012·Blood Cells, Molecules & Diseases·Marie-Catherine GiarratanaLuc Douay
May 20, 2011·Trends in Cell Biology·Peng JiHarvey F Lodish
Jan 18, 2011·European Journal of Internal Medicine·Giuseppe LippiMassimo Franchini
Nov 15, 2011·Blood·Harvey G Klein
Sep 1, 2017·Nature Methods·Juan C CaicedoAnne E Carpenter
Mar 13, 2012·Current Opinion in Hematology·David J AnsteeAshley M Toye
Nov 18, 2020·Stem Cell Research & Therapy·Mohsen EbrahimiMaryam Farzaneh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.